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Conclusion: Although BMI has been reported to be correlated to baro-
receptor sensibility, it doesn’t seem to influence HRV and HRT parameters in
hypertensive patients. The interpretation of HRV and HRT in hypertension
doesn’t need adjustment to BMI.
274
Assessment of the effect of antihypertension treatment on heart rate
variability in hypertensive patients 
Afef Ben Halima [Orateur], Mehdi Ben Miled, Manel Ben Halima, Rym
Chrigui, Samira Chine, Faouzi Addade, Sonia Marrakchi, Ikram Kam-
moun, Abdellatif Lefi, Salem Kachboura
Hôpital Abderrahmen Mami, Cardiologie, Ariana, Tunisie
Introduction: Heart rate variability (HRV) abnormalities have been sug-
gested to be associated with higher risk of occurrence of cardio-vascular
events. Several studies noticed HRV abnormalities in systemic hypertension.
Aim: The aim of this prospective study is to evaluate the effect of antihy-
pertensive treatment on temporal and spectral parameters of heart rate vari-
ability.
Methods: This study included 85 patients ( mean age 57±11 years and sex
ratio 0.88) followed up for hypertension. They underwent 24 hours Holter
recording and 24 hours ambulatory blood pressure monitoring (ABPM).
Thirty nine patients (45%) received diuretics, 49 patients (57%) were on ACE
or ARB, 42 patients (49%) were on B blockers, 39 patients (45%) received
calcium channel inhibitors and 8 patients (9%) were on central antihyperten-
sive treatment. Patients in different therapeutic groups were similar regarding
demographic characteristics and arterial systolic and diastolic pressure
Results: There was no significant difference in HRV parameters between
patients receiving ACE/ARB, those on calcium channel blockers, on diuretics
and patients receiving central antihypertensive treatment. We noticed that
HRV parameters tended to be more altered in patients receiving B blockers.
Conclusion: In our study most classes of antihypertension treatment don’t
affect the HRV parameters. The effect of B blockers is contreversial. Their
deleterious effect on HRV must be verified by larger studies.
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Objectives: to investigate relations between obesity, plasma cholesterol
level and structural changes of the heart in patients with combined ischemic
heart disease (IHD) and arterial hypertension (AH).
Material and methods: 35 patients (24 males and 11 females) with long-
standing IHD and AH were enrolled in the study. The average age of patients
was 54,2+8,1 years. All patients underwent routine clinical examinations
including anthropometry, office blood pressure (BP) measurement, echocar-
diography and measurement of fasting total cholesterol (TC) in plasma. Left
ventricular myocardial mass (LVMM) was calculated by Penn Convention
formula. Indexation of LVMM was made by height in 2.7 power. Left atrium
diameter (LAD) was measured in anterior-posterior direction. All patients
received conventional anti-ischemic and anti-hypertensive treatment regularly.
Results: Any significant correlations between BP in treated patients and
characteristics of cardiac remodeling were not found. Meanwhile, average BP
correlated significantly with BMI (r=0.51, p=0.002) and TC (r=0.59,
p<0.001). Moreover, increased BMI wasn’t associated with specific changes
in the heart structure except LAD (r=0.61, p<0.001), and LAD itself correlated
positively with LVMM index2.7 (r=0.72, p<0.001) and negatively with ejection
fraction of LV (r=–0.49, p=0.003). Interestingly, that age of patients correlated
only with diameter of ascending aorta (r=0.46, p=0.06) which increasing is
probably associated with pronounced atherosclerosis. Sex of patients had
impact on few values. Compare to females in this study males had higher
height (173.7+4.3 vs. 167.0+4.4 cm, p<0.001) and diameter of ascending aorta
(35.1+4.9 vs. 31.4+4.1 cm).
Conclusion: AH is more resistant for conventional treatment if associated
with obesity and hypercholesterolemia. Increasing of BMI is related to spe-
cific type of cardiac remodeling – namely – enlargement of left atrium (known
marker of pronounced diastolic dysfunction). Large left atrium is often com-
bined with LV hypertrophy and systolic dysfunction. Finally, diameter of
ascending aorta is more likely increased in males and in elderly age.
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The aim of the study was to estimate how the ankle-brahial blood pressure
index (ABPI) correlates with cardiovascular events at hypertensive patients
(pts) with or without metabolic syndrome (MS).
Methods: 40 hypertensive pts(mean age =57.1+/–7.5 years, 52.5% males)
– group 1 and 40 hypertensive pts with MS, matched for age and sex(mean
age =58.7+/–7.2 years, 55% males) – group 2. ABPI was evaluated using
ultrasound assessment of blood flow in posterior tibial artery and brachial
artery. ABPI smaller than 1 was considered abnormal. All pts were evaluated
during one year in order to detect the following complications: unstable
angina(UA),non-ST-segment elevation myocardial infarction(NSTEMI), tran-
sient ischemic stroke(TIS),ischemic stroke(IS).
Results: In group 1, 17 pts(42.5%) had reduced ABPI:0.62+/–0.24. In
group 2, 19 pts (47.5%) had reduced ABPI:0.54+/–0.16. The difference is not
significantly statistic between the two groups(p=0.12). In group1,UA was sig-
nificantly associated with reduced ABPI(0.64+/–0.26 vs 0.91+/–0.18,
p=0.04).In the same group,TIS was found in a significantly higher proportion at
pts with reduced ABPI(0.61+/–0.12 vs 1.02+/0.14, p=0.001). In group 2,UA was
also significantly associated with reduced ABPI (0.56 +/–0.11 vs 0.88+/–0.14,
p=0.02). NSTEMI was significantly more frequent at pts with reduced
ABPI(0.52+/–0.12 vs 0.93+/–0.16, p=0.002). In the same group, TIS was
found in a significantly higher proportion at pts with reduced ABPI (0.58+/–
0.14 vs 0.96+/–0.12, p=0.03).
Conclusions: Hypertensive pts with MS have reduced ABPI in a higher
but not significant proportion than hypertensive pts without MS. Reduced
ABPI seems to predict a worse mid term outcome (one year) concerning car-
diovascular events at hypertensive pts, especially with MS. Moreover, reduced
ABPI appears to have more powerful mid term prognostic value for incidence
of acute coronary syndrome without ST-segment elevation at hypertensive pts
with MS.
277
Abnormal circulating levels of metalloproteinase and their inhibitor
in hypertensive patients
Yosra Zayani (1), Monia Elasmi [Orateur] (2), Wiem Zidi (1), Moncef
Feki (1), Marie Paule Jacob (3), Naziha Kaabachi (1)
(1) CHU la Rabta, Research Laboratory LR99ES11, Biochemistry Labo-
ratory, Tunis, Tunisie – (2) CHU la Rabta, Laboratoire de Biochimie,
Tunis, Tunisie – (3) Inserm, UMR698, Hemostasis, Bio-Engineering and
Cardiovascular Remodelling, Paris, France
The aim of this study was to determine the plasma levels of Matrix metallopro-
teinases (MMPs): MMP-2, MMP-3, MMP-9, and their inhibitors (TIMPs):TIMP-1,
and TIMP-2 in hypertensive patients and healthy subjects. The study has involved
40 hypertensive patients and 41 adult healthy controls. The mean plasma activity
of pro-MMP9 in the hypertensive group and the control group were significantly
different (15.33±12.93 vs 90.38±97.49 103 densitometric units/ul; p<0.05). The
© Elsevier Masson SAS. All rights reserved.
 
88 Archives of Cardiovascular Diseases Supplements 2012) 4, 82-89
plasma concentration of MMP3 was significantly higher in hypertensive subjects
then healthy subjects (20.24±8.63 vs 16.41±6.8 ng/ml; p<0.05). Whereas the
plasma concentration of TIMP1 in the hypertensive group was significantly lower
than that in the control group 88.96±26.9 vs 93.96±27.28 ng/ml. The present study
identified abnormalities in plasma markers for extracellular matrix metabolism in
hypertensive patients.
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Introduction: We studied the effects of the angiotensinogen M235T,
angiotensin converting enzyme insertion/deletion (ACE I/D), and angiotensin
II receptor 1 (AT1R) A1166C gene polymorphisms on the risk of essential
hypertension (HTA).
Patients and methods: RAS gene polymorphisms were determined by
PCR and PCR-RFLP method in a total of 142 hypertensive patients and 191
control subjects.
Results: The three polymorphisms of renin-angiotensin system (RAS)
genes were significantly associated with HTA. The TT genotype and T allele
of AGT, DD genotype and D allele of ACE and, CC genotype and T allele of
AT1R polymorphisms were associated with increased risk of HTA. After
adjustment for sex, smoking, diabetes, dyslipidemia, BMI, total cholesterol,
LDL and HDL cholesterol, triglycerides and DD, TT and CC genotypes, BMI
was independent risk factor of HTA. An association of BMI with ACE gene
polymorphism, whereas no association with AGT and AT1R gene polymor-
phisms was obtained.
Conclusions: The present study implies that genotyping for the variants of
RAS gene could in the future become an important part of the clinical process
of risk identification for HTA in Tunisian population.
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This study was performed to evaluate the prevalence of peripheral arterial
disease ( PAD), among Algerian population aged over 40 years .
The prevalence of PAD is determined using ankle brachial index. The age
and sex adjusted according to the latest census 2008, prevalence is estimated
at 3.7%±0.8%. It is 6.9%±0.1% when it retains the lowest pressure ankle .
In this population of patients with PAD claudication is found in 32.9%
versus 1.2% in free population. Thus, PAD is asymptomatic in 67% of the
patients of PRAMIAL. Trophic disorders are rated 28.8% versus 0.5% in free
population. 2.9% had been amputated versus 0.004% in free population.
Sexual disorders were found in 14.9% of the patients with PAD versus 0.3%
in free population. Abolition of the pulse is observed in 15.3% versus 0.6% in
free population. An arterial murmur is observed in 10.3% versus 0.7% in free
population.
A multivariate logistic regression type has been made to appreciate the
own share of each risk factor in the occurrence of PAD.Echo Doppler lower
limb confirmed diagnosis of PAD objectifying significant abnormalities in
94.2% of cases. Carotid lesions have been observed in 49.4% of cases. Ath-
erosclerosis of abdominal aorta and its branches was observed in 13.8% in
celiac trunk or mesenteric artery, and abdominal aortic aneurysm, renal artery
stenosis. Coronary artery disease was found in 31.2% .
Prevalence of PAD in Algerian population is estimated at 3.7%±0.8% with
conventional measure of ABI . It is 6.9%±0.1% when it retains the lowest pressure
ankle . Six variables stand out as PAD very significant risk factors. Thus, by order
of penetrance, they are: PAD family history, family history of major cardiovas-
cular event, smoking, hypertension, Dyslipidemia and type 2 diabetes. Therapy
remain imperfect, only 29.4% of PAD patients received combination of anti-
platelet therapy, statin and Renin angiotensin system blocker
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Introduction: The daily profile of blood pressure measured by ambulatory
blood pressure of 24 on the change in the level of blood pressure and morning
blood pressure have been reported as a cardiovascular risk factor. On waking
in the morning, the sympathetic nervous system activity and the risk of car-
diovascular events is high.
Objective: To clarify the relationship between the daily profile of the
activity of the autonomic nervous system and blood pressure using ambulatory
blood pressure and 24 hour ECG monitoring.
Material and methods: One hundred patients with untreated essential
hypertension were included in this study. Patients with atrial arrhythmia or
ventricular heart with a history were excluded. We evaluated the autonomic
nervous system activity by measuring the RR interval using the Holter rhythm
of 24h. We calculated the average systolic blood pressure before and 2 hours
after waking. Patients were classified into 3 groups: decreased blood pressure
(n=22), elevated blood pressure less than 10% (n=36) and more than 10%
(n=42). The variability of the autonomic nervous system was assessed by
changes in RR interval.
Results: There was no significant difference between blood pressure and
heart rate before awakening, daytime and overnight in the 3 groups. The
average heart rate 2 hours after awakening was higher in the group with ele-
vated blood pressure over 10% (30.2±2.9) compared to the group that had a
decrease in blood pressure (10.1±1.5). Moreover, the decrease in heart rate
2 hours before awakening in patients who have an elevation of more than
10% (70±29%) blood pressure was higher than in those with BP decreased
(49.8±18%).
Conclusion: This study suggests that the elevation of blood pressure vari-
ability is associated with the autonomic nervous system in the morning and
not only to increase the activity of the sympathetic nervous system.
281
Prevalence of cardiovascular risk factors in Moroccan patients with
hypertension (about 200 cases)
Zannouba Elhonsali [Orateur], Meryem Alj, Naima Baaddy, Ahmed Ben-
nis
CHU Ibn Rochd, Cardiologie, Casablanca, Maroc
Introduction: Hypertension is a major cardiovascular risk factor. The rela-
tionship between the degree of hypertension and cardiovascular risk is contin-
uous and direct. The association of hypertension with other cardiovascular risk
factors accelerates and aggravates organ damage.
The purpose of this study is to determine the prevalence of cardiovascular
risk factors in patients with hypertension and the risk profile.
Materials and methods: We evaluated the lipid profile and glucose in
200 patients with hypertension.
Results: The mean age of patients was 47 years, 59.2% were women. The
lipid profile showed a significant difference in triglycerides and LDL-c. The
average value of triglycerides in hypertensive patients was 1.74±0.78 mmol/l
vs. 1.49±0.85 mmol/l in normotensives (P<0.005). The average LDL-c was
3.71±1.46 mmol/l vs. 3.35±1.46 mmol/l (P=0.001). There was no significant
difference in HDL-c in the 2 groups, mean value of 1.01±0.38 mmol/l in
hypertensives vs. 1.04±0.40mmol/l in normotensives, P=y 0.24. Il was a sig-
nificant difference for incidence of diabetes in hypertensive patients (p=0.03).
Conclusion: Hypertension is closely linked to other cardiovascular risk
factors including diabetes, high LDL-c and triglycerides. HDL-C was lower in
hypertensive patients without significant difference. 
